Tim Lugo


William Blair Offers Commentary on Sarepta Therapeutics Inc Following NDA Acceptance and Priority Review Designation

In a research report published today, William Blair analyst Tim Lugo reiterated an Outperform rating on shares of Sarepta Therapeutics Inc (NASDAQ:SRPT) with a price …

William Blair Reiterates Market Perform on Zogenix, Inc. Following Second Quarter Earnings

In a research report released Tuesday, William Blair analyst Tim Lugo reiterated a Market Perform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX), after the company released …

William Blair Offers Commentary on Akorn, Inc. Following Earnings Restatement

Akorn, Inc. (NASDAQ:AKRX) dropped 22% yesterday after announcing the discovery of additional errors related to Hi-Tech products during the first-quarter accounting process, which will delay …

William Blair Reiterates Outperform On Biodelivery As It Acquires North American Rights To Pain Patch

In a research report sent to investors, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a price …

UPDATE: William Blair Raises Auspex Pharmaceuticals Price Target Following SD-809 Phase III Results

In a research report released today, William Blair analyst Tim Lugo maintained an Outperform rating on Auspex Pharmaceuticals (NASDAQ:ASPX) and raised his price …

William Blair Reiterates Outperform On Biodelivery Sciences Following Management Meetings With investors

In a research report published today, William Blair analyst Tim Lugo reiterated an Outperform rating on Biodelivery Sciences (NASDAQ:BDSI) with a $25 price …

Shire: William Blair Gives Quick Take On Third-Quarter Earnings; Maintains Market Perform

In a research report issued late Friday, William Blair analyst Tim Lugo assigned a Market Perform rating on Shire PLC (NASDAQ:SHPG) with a price …

William Blair Assigns Outperform On Sarepta Therapeutics Shares, $63 PT

In a research report issued today, William Blair analyst Tim Lugo assigned an Outperform rating on Sarepta Therapeutics Inc. (NASDAQ:SRPT) with a price …

William Blair Maintains Market Perform On Shire, $250 PT

In a research report issued today, William Blair analyst Tim Lugo maintained a Market Perform rating on Shire PLC (NASDAQ:SHPG) with a price …

William Blair Remains Bullish On BioDelivery Following Launch Update

In a research report issued Wednesday, William Blair analyst Tim Lugo maintained an Outperform rating on BioDelivery Sciences International (NASDAQ:BDSI) with a $25 price …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts